TrialNeurology(R) neuroimmunology & neuroinflammation2024

Safety and Dose-Response of Vidofludimus Calcium in Relapsing Multiple Sclerosis: Extended Results of a Placebo-Controlled Phase 2 Trial.

Robert J Fox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.